Award

2024YFA1210201

Funder: National Key Research and Development Program of China

Funded outputs count: 8

Funder award ID: 2024YFA1210201

OpenAlex ID: G2100470541

Leptomeningeal fibroblasts promote glioblastoma progression by regulating cerebrospinal fluid dynamics

2026 · Maoyuan Sun, Shan Jiang, et al. · Nature Communications

Biomimetic Macrophage Cell Membrane‐Based Nanoparticles for Effective Treatment of Glioblastoma Through Boron Neutron Capture Therapy Combined With Immunotherapy

2026 · Jiawen Chen, Haoyu You, et al. · Advanced Science

Bone Marrow Homing and GPRC5D‐Targeting Engineered Cell Membrane‐Camouflaged Hypoxia‐Responsive Nanoparticles for Multiple Myeloma Therapy

2026 · Bingyang Chu, Shiqian Li, et al. · Advanced Functional Materials

Melphalan-loaded micelles for intravitreal chemotherapy of retinoblastoma

2026 · Hanyue Xu, Ying Qu, et al. · Chinese Chemical Letters

Integrated detection of cerebrospinal fluid cfDNA/cfRNA and molecular concordance with glioma characteristics

2026 · Maoyuan Sun, Shan Jiang, et al. · Neuro-Oncology Advances · 2

Interleukin-8-induced tumor self-rampart spatially confines oncolytic virotherapy in glioblastoma

2025 · Shan Jiang, Houshi Xu, et al. · Neuro-Oncology · 1

Decoding age-stratified mutational landscapes in CNS lymphoma via genomic and survival profiling for precision oncology

2025 · Jiawen Chen, Hongwei Liu, et al. · Genes & Diseases

Neural stem cell-delivered oncolytic virus via intracerebroventricular administration enhances glioblastoma therapy and immune modulation

2025 · Huihui Chai, Houshi Xu, et al. · Journal for ImmunoTherapy of Cancer · 9